AKT1 and prostate cancer: More interestingly, we found that 2-O-Bn-InsP5 was able to block Akt phosphorylation in cell lines resistant to InsP5, such as prostate cancer cells PC3 (Figure 1C) and pancreatic cancer cells ASPC1 (results not shown).